{"entity":{"type":"insider","cik":"0001310683","url":"/insider/0001310683","json_url":"/insider/0001310683.json","name":"Culley Brian M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2010-05-27","last":"2026-03-12","span_basis":"filed_date"},"name_variants":[{"name":"Culley Brian M","source":"filing","n_filings":12,"first_seen":"2010-05-27","last_seen":"2026-03-12"}],"transactions":[{"id":5870542,"accession":"0001193125-26-104106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-104106","line_url":"/filing/0001193125-26-104106#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.625,"price_display":"1.62","price_state":"stated","total_value":24375.0,"total_display":"24,375.00","total_whole":"24,375","shares_owned_after":255516.0,"shares_owned_after_display":"255,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-12","scope":"insider"},{"id":2350501,"accession":"0000950170-24-129972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129972","line_url":"/filing/0000950170-24-129972#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","total_whole":"24,000","shares_owned_after":194842.0,"shares_owned_after_display":"194,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-22","scope":"insider"},{"id":2304460,"accession":"0000950170-24-064896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-064896","line_url":"/filing/0000950170-24-064896#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","total_whole":"10,500","shares_owned_after":154842.0,"shares_owned_after_display":"154,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-24","filed_date":"2024-05-28","scope":"insider"},{"id":6483639,"accession":"0001493152-22-009000","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-22-009000","line_url":"/filing/0001493152-22-009000#line-3","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6400.0,"shares_display":"6,400","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":9792.0,"total_display":"9,792.00","total_whole":"9,792","shares_owned_after":97787.0,"shares_owned_after_display":"97,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-04","scope":"insider"},{"id":6091327,"accession":"0001493152-22-007925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-007925","line_url":"/filing/0001493152-22-007925#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5250.0,"shares_display":"5,250","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":7245.0,"total_display":"7,245.00","total_whole":"7,245","shares_owned_after":81280.0,"shares_owned_after_display":"81,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-28","scope":"insider"},{"id":4897547,"accession":"0001493152-21-015778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-015778","line_url":"/filing/0001493152-21-015778#line-2","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450000.0,"shares_display":"450,000","price_per_share":2.87,"price_display":"2.87","price_state":"stated","total_value":1291500.0,"total_display":"1,291,500.00","total_whole":"1,291,500","shares_owned_after":45709.0,"shares_owned_after_display":"45,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":8493013,"accession":"0001209191-19-046029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046029","line_url":"/filing/0001209191-19-046029#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":10100.0,"total_display":"10,100.00","total_whole":"10,100","shares_owned_after":84531.0,"shares_owned_after_display":"84,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-15","scope":"insider"},{"id":4238143,"accession":"0001178913-17-002876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-17-002876","line_url":"/filing/0001178913-17-002876#line-1","is_derivative":false,"issuer_cik":"0001062128","issuer_name":"Artemis Therapeutics, Inc.","issuer_ticker":"ATMS","issuer_name_source":null,"issuer_url":"/issuer/0001062128","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-25","scope":"insider"},{"id":3381060,"accession":"0001209191-12-018530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-018530","line_url":"/filing/0001209191-12-018530#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"ADVENTRX PHARMACEUTICALS INC","issuer_ticker":"ANX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20500.0,"shares_display":"20,500","price_per_share":0.5904,"price_display":"0.59","price_state":"stated","total_value":12103.2,"total_display":"12,103.20","total_whole":"12,103","shares_owned_after":34500.0,"shares_owned_after_display":"34,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-14","filed_date":"2012-03-15","scope":"insider"},{"id":3323374,"accession":"0001209191-12-018272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-018272","line_url":"/filing/0001209191-12-018272#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"ADVENTRX PHARMACEUTICALS INC","issuer_ticker":"ANX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Director, Officer (CEO and Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":0.5817,"price_display":"0.58","price_state":"stated","total_value":8143.8,"total_display":"8,143.80","total_whole":"8,144","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-13","filed_date":"2012-03-14","scope":"insider"},{"id":8996462,"accession":"0001209191-11-032979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-032979","line_url":"/filing/0001209191-11-032979#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"ADVENTRX PHARMACEUTICALS INC","issuer_ticker":"ANX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":12200.0,"total_display":"12,200.00","total_whole":"12,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-02","filed_date":"2011-06-03","scope":"insider"},{"id":7610269,"accession":"0001209191-10-030827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-030827","line_url":"/filing/0001209191-10-030827#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"ADVENTRX PHARMACEUTICALS INC","issuer_ticker":"ANX","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001310683","owner_name":"Culley Brian M","owner_display_name":"Culley Brian M","owner_url":"/insider/0001310683","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":9450.0,"total_display":"9,450.00","total_whole":"9,450","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-27","filed_date":"2010-05-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"Lineage Cell Therapeutics, Inc.","url":"/issuer/0000876343","role":"Director, Officer (President and CEO)","n_filings":7,"first_seen":"2019-08-15","last_seen":"2026-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001062128","name":"Artemis Therapeutics, Inc.","url":"/issuer/0001062128","role":"Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2017-10-25","last_seen":"2017-10-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001160308","name":"ADVENTRX PHARMACEUTICALS INC","url":"/issuer/0001160308","role":"Director, Officer (CEO and Director)","n_filings":4,"first_seen":"2010-05-27","last_seen":"2012-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001310683","retrieved_at":"2026-08-26T23:06:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}